FDA Perspective on the Importance of Digital Health Technologies in Clinical Trials
Elizabeth Kunkoski, Anindita Saha, Maria Matilde Kam
Abstract
This Viewpoint discusses how increasing access to and the use of digital health technologies in clinical trials can enable clinical trials with decentralized elements that are representative of the target population.
Topics & Concepts
Clinical trialPerspective (graphical)Population healthPopulationMedicineComputer scienceEnvironmental healthPathologyArtificial intelligenceMobile Health and mHealth ApplicationsBiomedical and Engineering EducationArtificial Intelligence in Healthcare and Education